Resuscitating the Field of Cardiac Regeneration: Seeking Answers from Basic Biology.
Yaching HsuKe ChengKe ChengPublished in: Advanced biology (2021)
Heart failure (HF) is one of the leading causes for hospital admissions worldwide. HF patients are classified based on the chronic changes in left ventricular ejection fraction (LVEF) as preserved (LVEF ≥ 50%), reduced (LVEF ≤ 40%), or mid-ranged (40% < LVEF < 50%) HFs. Treatments nowadays can prevent HFrEF progress, whereas only a few of the treatments have been proven to be effective in improving the survival of HFpEF. In this review, numerous mediators involved in the pathogenesis of HF are summarized. The regional upstream signaling and their diagnostic and therapeutic potential are also discussed. Additionally, the recent challenges and development in cardiac regenerative therapy that hold opportunities for future research and clinical translation are discussed.
Keyphrases
- ejection fraction
- left ventricular
- aortic stenosis
- heart failure
- stem cells
- acute heart failure
- end stage renal disease
- cardiac resynchronization therapy
- acute myocardial infarction
- hypertrophic cardiomyopathy
- chronic kidney disease
- mitral valve
- mental health
- mesenchymal stem cells
- newly diagnosed
- left atrial
- current status
- peritoneal dialysis
- atrial fibrillation
- patient reported outcomes
- smoking cessation